Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 899

1.

NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization.

Schotten C, Bechmann LP, Manka P, Theysohn J, Dechêne A, El Fouly A, Barbato F, Neumann U, Radünz S, Sydor S, Heider D, Venerito M, Canbay A, Gerken G, Herrmann K, Wedemeyer H, Best J.

Liver Cancer. 2019 Nov;8(6):491-504. doi: 10.1159/000501484. Epub 2019 Jul 29.

PMID:
31799206
2.

A Conversation Between Stefano Buono and Ken Herrmann.

Buono S, Herrmann K.

J Nucl Med. 2019 Dec;60(12):1659-1662. doi: 10.2967/jnumed.119.238212. No abstract available.

PMID:
31792127
3.

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort: Under the Auspices of the EAU-ESMO Guidelines Committees.

Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Der Kwast TV, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, De Bari B, De Blok W, J L De Visschere P, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, J G Oyen W, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Der Heijden AGV, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T, Wiklund P, Williams A, Zigeuner R, Horwich A.

Eur Urol. 2019 Nov 16. pii: S0302-2838(19)30763-8. doi: 10.1016/j.eururo.2019.09.035. [Epub ahead of print]

PMID:
31753752
4.

EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.

Horwich A, Babjuk M, Bellmunt J, Bruins HM, Reijke TM, Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Kwast TV, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, Bari B, Blok W, De Visschere PJL, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, Oyen WJG, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Van Der Heijden AG, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T, Wiklund P, Williams A, Zigeuner R, Witjes JA.

Ann Oncol. 2019 Nov 19. pii: mdz296. doi: 10.1093/annonc/mdz296. [Epub ahead of print]

PMID:
31740927
5.

Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinoma.

Ferrone C, Goyal L, Qadan M, Gervais D, Sahani DV, Zhu AX, Hong TS, Blaszkowsky LS, Tanabe KK, Vangel M, Amorim BJ, Wo JY, Mahmood U, Pandharipande PV, Catana C, Duenas VP, Collazo YQ, Canamaque LG, Domachevsky L, Bernstine HH, Groshar D, Shih TT, Li Y, Herrmann K, Umutlu L, Rosen BR, Catalano OA.

Eur J Nucl Med Mol Imaging. 2019 Nov 16. doi: 10.1007/s00259-019-04558-3. [Epub ahead of print]

PMID:
31705172
6.

Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patients.

Vaz S, Hadaschik B, Gabriel M, Herrmann K, Eiber M, Costa D.

Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):9-15. doi: 10.1007/s00259-019-04529-8. No abstract available.

PMID:
31654093
7.

18F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis: a randomized controlled trial.

Li Y, Schaarschmidt B, Umutlu L, Forsting M, Demircioglu A, Koch AK, Martin O, Herrmann K, Juette H, Tannapfel A, Langhorst J.

Eur J Nucl Med Mol Imaging. 2019 Oct 24. doi: 10.1007/s00259-019-04535-w. [Epub ahead of print]

PMID:
31650217
8.

PET/MR Imaging of the Female Pelvis.

Umutlu L, Antoch G, Herrmann K, Grueneisen J.

Semin Nucl Med. 2019 Nov;49(6):512-520. doi: 10.1053/j.semnuclmed.2019.06.013. Epub 2019 Jul 16. Review.

PMID:
31630735
9.

MRI as an alternative to serum ferritin for diagnosis of iron overload in children in the context of immune response after stem cell transplantation.

Wurschi GW, Mentzel HJ, Herrmann KH, Krumbein I, Beck JF, Reichenbach JR, Kentouche K.

Pediatr Transplant. 2019 Dec;23(8):e13583. doi: 10.1111/petr.13583. Epub 2019 Sep 18.

PMID:
31535426
10.

Reply by Authors.

Farolfi A, Gafita A, Calais J, Eiber M, Afshar-Oromieh A, Spohn F, Barbato F, Weber M, Ilhan H, Cervati V, Wetter A, Hadaschik B, Briganti A, Walz J, Pianori D, Fanti S, Haberkorn U, Herrmann K, Fendler WP.

J Urol. 2019 Dec;202(6):1181. doi: 10.1097/01.JU.0000582680.86998.12. Epub 2019 Sep 16. No abstract available.

PMID:
31524577
11.

Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer.

Fendler WP, Weber M, Iravani A, Hofman MS, Calais J, Czernin J, Ilhan H, Saad F, Small EJ, Smith MR, Perez PM, Hope TA, Rauscher I, Londhe A, Lopez-Gitlitz A, Cheng S, Maurer T, Herrmann K, Eiber M, Hadaschik B.

Clin Cancer Res. 2019 Sep 11. doi: 10.1158/1078-0432.CCR-19-1050. [Epub ahead of print]

PMID:
31511295
12.

Post-radiosynovectomy imaging utilizing Erbium-169 citrate.

Farahati J, Kazek S, Maric I, Soestwoehner T, Kalle P, Costa PF, Jentzen W, Stein L, Jalilian A, Kumm D, Bockisch A, Herrmann K.

Appl Radiat Isot. 2019 Dec;154:108853. doi: 10.1016/j.apradiso.2019.108853. Epub 2019 Aug 12.

PMID:
31493660
13.

Help or hurt? How attention modulates tics under different conditions.

Herrmann K, Sprenger A, Baumung L, Alvarez-Fischer D, Münchau A, Brandt V.

Cortex. 2019 Nov;120:471-482. doi: 10.1016/j.cortex.2019.06.016. Epub 2019 Jul 18.

PMID:
31491584
14.

Whole-Body Integrated [68Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer: Comparison with Whole-Body PET/CT as the Standard of Reference.

Guberina N, Hetkamp P, Ruebben H, Fendler W, Grueneisen J, Suntharalingam S, Kirchner J, Puellen L, Harke N, Radtke JP, Umutlu L, Hadaschik BA, Herrmann K, Forsting M, Wetter A.

Mol Imaging Biol. 2019 Sep 3. doi: 10.1007/s11307-019-01424-4. [Epub ahead of print]

PMID:
31482413
15.

Driving the Future of Nuclear Medicine.

Herrmann K, Veit-Haibach P, Weber WA.

J Nucl Med. 2019 Sep;60(Suppl 2):1S-2S. doi: 10.2967/jnumed.119.232264. No abstract available.

PMID:
31481584
16.

Animal Research, Accountability, Openness and Public Engagement: Report from an International Expert Forum.

Ormandy EH, Weary DM, Cvek K, Fisher M, Herrmann K, Hobson-West P, McDonald M, Milsom W, Rose M, Rowan A, Zurlo J, von Keyserlingk MAG.

Animals (Basel). 2019 Aug 29;9(9). pii: E622. doi: 10.3390/ani9090622.

17.

EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT).

Kratochwil C, Fendler WP, Eiber M, Baum R, Bozkurt MF, Czernin J, Delgado Bolton RC, Ezziddin S, Forrer F, Hicks RJ, Hope TA, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy FM, Oyen W, Rahbar K, Schöder H, Virgolini I, Wester HJ, Bodei L, Fanti S, Haberkorn U, Herrmann K.

Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2536-2544. doi: 10.1007/s00259-019-04485-3. Epub 2019 Aug 22.

PMID:
31440799
18.

mDixon-Based Synthetic CT Generation for PET Attenuation Correction on Abdomen and Pelvis Jointly Using Transfer Fuzzy Clustering and Active Learning-Based Classification.

Qian P, Chen Y, Kuo JW, Zhang YD, Jiang Y, Zhao K, Helo RA, Friel H, Baydoun A, Zhou F, Heo JU, Avril N, Herrmann K, Ellis R, Traughber B, Jones RS, Wang S, Su KH, Muzic RF.

IEEE Trans Med Imaging. 2019 Aug 16. doi: 10.1109/TMI.2019.2935916. [Epub ahead of print]

PMID:
31425065
19.

[Future Workshop 1.0 - Departure into the future or a flash in the pan?]

Herrmann K, Freudenberg LS.

Nuklearmedizin. 2019 Aug;58(4):297-300. doi: 10.1055/a-0918-5652. Epub 2019 Aug 14. German. No abstract available.

PMID:
31412393
20.

Beyond the 3Rs: Expanding the use of human-relevant replacement methods in biomedical research.

Herrmann K, Pistollato F, Stephens ML.

ALTEX. 2019;36(3):343-352. doi: 10.14573/altex.1907031.

21.

Can the injected dose be reduced in 68Ga-PSMA-11 PET/CT maintaining high image quality for lesion detection?

Rauscher I, Fendler WP, Hope T, Quon A, Nekolla SG, Calais J, Richter A, Haller B, Herrmann K, Weber WA, Czernin J, Eiber M.

J Nucl Med. 2019 Jul 19. pii: jnumed.119.227207. doi: 10.2967/jnumed.119.227207. [Epub ahead of print]

PMID:
31324710
22.

The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancer.

Weber M, Binse I, Nagarajah J, Bockisch A, Herrmann K, Jentzen W.

Q J Nucl Med Mol Imaging. 2019 Sep;63(3):235-252. doi: 10.23736/S1824-4785.19.03201-1. Epub 2019 Jul 11.

PMID:
31298014
23.

A Conversation Between Susanne Schaffert and Ken Herrmann.

Schaffert S, Herrmann K.

J Nucl Med. 2019 Jul;60(7):875-878. doi: 10.2967/jnumed.119.231035. No abstract available.

PMID:
31263079
24.

Engineered phytases for emerging biotechnological applications beyond animal feeding.

Herrmann KR, Ruff AJ, Infanzón B, Schwaneberg U.

Appl Microbiol Biotechnol. 2019 Aug;103(16):6435-6448. doi: 10.1007/s00253-019-09962-1. Epub 2019 Jun 28. Review.

PMID:
31254000
25.

Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors.

Lütje S, Heskamp S, Franssen GM, Frielink C, Kip A, Hekman M, Fracasso G, Colombatti M, Herrmann K, Boerman OC, Gotthardt M, Rijpkema M.

Theranostics. 2019 May 4;9(10):2924-2938. doi: 10.7150/thno.35274. eCollection 2019.

26.

EJNMMI supplement: bringing AI and radiomics to nuclear medicine.

Veit-Haibach P, Buvat I, Herrmann K.

Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2627-2629. doi: 10.1007/s00259-019-04395-4. No abstract available.

PMID:
31240329
27.

68Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective Study.

Farolfi A, Gafita A, Calais J, Eiber M, Afshar-Oromieh A, Spohn F, Barbato F, Weber M, Ilhan H, Cervati V, Wetter A, Hadaschik B, Briganti A, Walz J, Pianori D, Fanti S, Haberkorn U, Herrmann K, Fendler WP.

J Urol. 2019 Dec;202(6):1174-1181. doi: 10.1097/JU.0000000000000417. Epub 2019 Jun 24.

PMID:
31233369
28.

Molecular Imaging for Primary Staging of Prostate Cancer.

Pomykala KL, Farolfi A, Hadaschik B, Fendler WP, Herrmann K.

Semin Nucl Med. 2019 Jul;49(4):271-279. doi: 10.1053/j.semnuclmed.2019.02.004. Epub 2019 Mar 20. Review.

PMID:
31227050
29.

Renal cystic lesions characterization using spectral detector CT (SDCT): Added value of spectral results.

Kessner R, Große Hokamp N, Ciancibello L, Ramaiya N, Herrmann KA.

Br J Radiol. 2019 Aug;92(1100):20180915. doi: 10.1259/bjr.20180915. Epub 2019 May 24.

PMID:
31124701
30.

UTE-mDixon-based thorax synthetic CT generation.

Su KH, Friel HT, Kuo JW, Al Helo R, Baydoun A, Stehning C, Crisan AN, Traughber MS, Devaraj A, Jordan DW, Qian P, Leisser A, Ellis RJ, Herrmann KA, Avril N, Traughber BJ, Muzic RF Jr.

Med Phys. 2019 Aug;46(8):3520-3531. doi: 10.1002/mp.13574. Epub 2019 Jun 12.

PMID:
31063248
31.

[Morphologic diagnostic criteria of noninvasive follicular neoplasia with papillary-like nuclear features (NIFTP) : A diagnostic challenge for the patient's benefit].

Theurer S, Dralle H, Führer-Sakel D, Herrmann K, Schmid KW.

Pathologe. 2019 May;40(3):220-226. doi: 10.1007/s00292-019-0597-0. German.

PMID:
31049677
32.

[PSA increase after definitive treatment].

Maurer T, Hadaschik B, Budäus L, Steuber T, Salomon G, Horn T, Herrmann K, Weber M, Giesel FL, Berliner C, Eiber M.

Urologe A. 2019 May;58(5):569-582. doi: 10.1007/s00120-019-0931-4. German.

PMID:
31049635
33.

Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments.

Farolfi A, Fendler W, Iravani A, Haberkorn U, Hicks R, Herrmann K, Walz J, Fanti S.

Eur Urol Oncol. 2019 Mar;2(2):152-162. doi: 10.1016/j.euo.2019.01.001. Epub 2019 Jan 31. Review.

PMID:
31017091
34.

Comparison of L-Methyl-11C-Methionine PET With Magnetic Resonance Spectroscopy in Detecting Newly Diagnosed Glioma.

Kebir S, Lazaridis L, Weber M, Deuschl C, Stoppek AK, Schmidt T, Mönninghoff C, Blau T, Keyvani K, Umutlu L, Pierscianek D, Forsting M, Stuschke M, Antoch G, Sure U, Kleinschnitz C, Scheffler B, Colletti PM, Rubello D, Herrmann K, Glas M.

Clin Nucl Med. 2019 Jun;44(6):e375-e381. doi: 10.1097/RLU.0000000000002577.

PMID:
30985412
35.

Production of [11C]Formaldehyde by the XeF2 mediated oxidation of [11C]Methanol and its application in the labeling of α-(N-[11C]Methylamino)isobutyric acid.

Nader M, Oberdorfer F, Herrmann K.

Appl Radiat Isot. 2019 Jun;148:178-183. doi: 10.1016/j.apradiso.2019.03.032. Epub 2019 Mar 31. No abstract available.

PMID:
30959355
36.

Propentdyopents as Heme Degradation Intermediates Constrict Mouse Cerebral Arterioles and Are Present in the Cerebrospinal Fluid of Patients With Subarachnoid Hemorrhage.

Joerk A, Ritter M, Langguth N, Seidel RA, Freitag D, Herrmann KH, Schaefgen A, Ritter M, Günther M, Sommer C, Braemer D, Walter J, Ewald C, Kalff R, Reichenbach JR, Westerhausen M, Pohnert G, Witte OW, Holthoff K.

Circ Res. 2019 Jun 7;124(12):e101-e114. doi: 10.1161/CIRCRESAHA.118.314160. Epub 2019 Apr 5.

PMID:
30947629
37.

Evaluation of liver tissue by ultrasound elastography and clinical parameters in children with multiple blood cell transfusions.

Wurschi GW, Kentouche K, Herrmann KH, Krumbein I, Nold M, Beck JF, Reichenbach JR, Mentzel HJ.

Pediatr Radiol. 2019 Jun;49(7):897-905. doi: 10.1007/s00247-019-04382-9. Epub 2019 Mar 29.

PMID:
30927037
38.

18F-FDG PET/MRI for Therapy Response Assessment of Isolated Limb Perfusion in Patients with Soft-Tissue Sarcomas.

Grueneisen J, Schaarschmidt B, Demircioglu A, Chodyla M, Martin O, Bertram S, Wetter A, Bauer S, Fendler WP, Podleska L, Forsting M, Herrmann K, Umutlu L.

J Nucl Med. 2019 Nov;60(11):1537-1542. doi: 10.2967/jnumed.119.226761. Epub 2019 Mar 29.

PMID:
30926647
39.

Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial.

Fendler WP, Calais J, Eiber M, Flavell RR, Mishoe A, Feng FY, Nguyen HG, Reiter RE, Rettig MB, Okamoto S, Emmett L, Zacho HD, Ilhan H, Wetter A, Rischpler C, Schoder H, Burger IA, Gartmann J, Smith R, Small EJ, Slavik R, Carroll PR, Herrmann K, Czernin J, Hope TA.

JAMA Oncol. 2019 Jun 1;5(6):856-863. doi: 10.1001/jamaoncol.2019.0096.

40.

Changing trends of incidence and prognosis of thyroid carcinoma.

Farahati J, Mäder U, Gilman E, Görges R, Maric I, Binse I, Hänscheid H, Herrmann K, Buck A, Bockisch A.

Nuklearmedizin. 2019 Mar;58(2):86-92. doi: 10.1055/a-0859-7454. Epub 2019 Mar 27.

PMID:
30917397
41.

Application of exopolysaccharide-forming lactic acid bacteria in cooked ham model systems.

Hilbig J, Loeffler M, Herrmann K, Weiss J.

Food Res Int. 2019 May;119:761-768. doi: 10.1016/j.foodres.2018.10.058. Epub 2018 Oct 31.

PMID:
30884714
42.

Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation.

Umutlu L, Beyer T, Grueneisen JS, Rischpler C, Quick HH, Veit-Haibach P, Eiber M, Purz S, Antoch G, Gatidis S, Nikolaou K, Schaefer JF, Rausch I, Herrmann K; Vorstand der Interdisziplinären AG für Hybride Bildgebung in alphabetischer Reihenfolge:; Vorstand der Deutschen Röntgengesellschaft (DRG) und der Deutschen Gesellschaft für Nuklearmedizin (DGN) in alphabetischer Reihenfolge:.

Nuklearmedizin. 2019 Mar;58(2):68-76. doi: 10.1055/a-0830-4453. Epub 2019 Feb 28.

43.

Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation.

Umutlu L, Beyer T, Grueneisen JS, Rischpler C, Quick HH, Veit-Haibach P, Eiber M, Purz S, Antoch G, Gatidis S, Nikolaou K, Schaefer JF, Rausch I, Herrmann K; Vorstand der Interdisziplinären AG für Hybride Bildgebung in alphabetischer Reihenfolge:; Vorstand der Deutschen Röntgengesellschaft (DRG) und der Deutschen Gesellschaft für Nuklearmedizin (DGN) in alphabetischer Reihenfolge:.

Rofo. 2019 Apr;191(4):289-297. doi: 10.1055/a-0828-8654. Epub 2019 Feb 28.

44.

Novel Structured Reporting Systems for Theranostic Radiotracers.

Werner RA, Bundschuh RA, Bundschuh L, Fanti S, Javadi MS, Higuchi T, Weich A, Pienta KJ, Buck AK, Pomper MG, Gorin MA, Herrmann K, Lapa C, Rowe SP.

J Nucl Med. 2019 May;60(5):577-584. doi: 10.2967/jnumed.118.223537. Epub 2019 Feb 22.

45.

Anterior Chamber Angle, Volume, and Depth in a Normative Cohort-A Retrospective Cross-Sectional Study.

Shajari M, Herrmann K, Bühren J, Vunnava P, Vounotrypidis E, Müller M, Al-Khateeb G, Kohnen T.

Curr Eye Res. 2019 Jun;44(6):632-637. doi: 10.1080/02713683.2019.1576205. Epub 2019 Feb 18.

PMID:
30747543
46.

The beginning of the end for conventional RECIST - novel therapies require novel imaging approaches.

Gerwing M, Herrmann K, Helfen A, Schliemann C, Berdel WE, Eisenblätter M, Wildgruber M.

Nat Rev Clin Oncol. 2019 Jul;16(7):442-458. doi: 10.1038/s41571-019-0169-5. Review.

PMID:
30718844
47.
48.

Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trial.

Guberina M, Eberhardt W, Stuschke M, Gauler T, Aigner C, Schuler M, Stamatis G, Theegarten D, Jentzen W, Herrmann K, Pöttgen C.

Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1439-1447. doi: 10.1007/s00259-019-4270-x. Epub 2019 Feb 1.

PMID:
30710323
49.

The application of humane endpoints and humane killing methods in animal research proposals: A retrospective review.

Herrmann K, Flecknell P.

Altern Lab Anim. 2018 Dec;46(6):317-333. Review.

PMID:
30657328
50.

In Vitro and In Vivo Characterization of an 18F-AlF-Labeled PSMA Ligand for Imaging of PSMA-Expressing Xenografts.

Lütje S, Franssen GM, Herrmann K, Boerman OC, Rijpkema M, Gotthardt M, Heskamp S.

J Nucl Med. 2019 Jul;60(7):1017-1022. doi: 10.2967/jnumed.118.218941. Epub 2019 Jan 17.

PMID:
30655329

Supplemental Content

Loading ...
Support Center